What is SCOPE of Pain?
Chronic pain affects approximately 100 million in the US, making it one of the most common reasons for patients to seek medical care. Unfortunately, pain management, including the appropriate use of opioids, is not well covered in medical training. Moreover, there are inadequate numbers of pain management specialists to help generalist providers manage these patients.
Partly in response to the problem of under-treatment of pain, over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.
Providers who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. Our educational program looks to address that need.
The FDA has mandated manufacturers of extended release/long-acting (ER/LA) opioid analgesics, as part of a comprehensive Risk Evaluation and Mitigation Strategy (REMS), to make available comprehensive prescriber education in the safe use of these medications based on the FDA curriculum known as the Blueprint for Prescriber Education for Extended Release and Long-Acting Opioid(ER/LA) Analgesics. Our curriculum covers all aspects of this blueprint and more to provide a comprehensive educational program.
After you have attended one of the SCOPE of Pain live meetings or completed the SCOPE of Pain online program, we suggest that you visit OpioidPrescribing.org. This online program provides in-depth training that focuses on effective communication skills as well as the potential risks and benefits of opioids and when and how to initiate, maintain, modify, continue or discontinue opioid therapy.